 | • レポートコード：GIR-105X09697 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、インターベンショナルX線造影剤＆造影剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。インターベンショナルX線造影剤＆造影剤の種類別市場規模（ヨウ素化造影剤、バリウムベース造影剤、マイクロバブル造影剤、その他）、用途別市場規模（心臓病、神経学、泌尿器科、一般手術、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・インターベンショナルX線造影剤＆造影剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bracco、General Electric、Guerbet、Fujifilm Visualsonics、Imax、J.B. Chemicals & Pharmaceuticals、Jodas Expoim、Lantheus Medical Imaging、Nano Therapeutics、Novalek Pharmaceuticals、Taejoon Pharm、Unijules Life Sciences ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ヨウ素化造影剤、バリウムベース造影剤、マイクロバブル造影剤、その他 ・用途別分析2016年-2026年：心臓病、神経学、泌尿器科、一般手術、その他 ・インターベンショナルX線造影剤＆造影剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・インターベンショナルX線造影剤＆造影剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・インターベンショナルX線造影剤＆造影剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・インターベンショナルX線造影剤＆造影剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・インターベンショナルX線造影剤＆造影剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Interventional X-ray Contrast and Imaging Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Interventional X-ray Contrast and Imaging Agents size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Interventional X-ray Contrast and Imaging Agents market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Interventional X-ray Contrast and Imaging Agents market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Iodinated Contrast Media
Barium-Based Contrast Media
Microbubble Contrast Media
Other
Market segment by Application can be divided into
Heart Disease
Neurological
Urology
General Surgery
Other
The key market players for global Interventional X-ray Contrast and Imaging Agents market are listed below:
Bracco
General Electric
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
Unijules Life Sciences
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Interventional X-ray Contrast and Imaging Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Interventional X-ray Contrast and Imaging Agents Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Iodinated Contrast Media
1.2.3 Barium-Based Contrast Media
1.2.4 Microbubble Contrast Media
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Interventional X-ray Contrast and Imaging Agents Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Heart Disease
1.3.3 Neurological
1.3.4 Urology
1.3.5 General Surgery
1.3.6 Other
1.4 Global Interventional X-ray Contrast and Imaging Agents Market Size & Forecast
1.4.1 Global Interventional X-ray Contrast and Imaging Agents Sales in Value (2016-2026))
1.4.2 Global Interventional X-ray Contrast and Imaging Agents Sales in Volume (2016-2026)
1.4.3 Global Interventional X-ray Contrast and Imaging Agents Price by Type (2016-2026) & (USD/MT)
1.5 Global Interventional X-ray Contrast and Imaging Agents Production Capacity Analysis
1.5.1 Global Interventional X-ray Contrast and Imaging Agents Total Production Capacity (2016-2026)
1.5.2 Global Interventional X-ray Contrast and Imaging Agents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Interventional X-ray Contrast and Imaging Agents Market Drivers
1.6.2 Interventional X-ray Contrast and Imaging Agents Market Restraints
1.6.3 Interventional X-ray Contrast and Imaging Agents Trends Analysis
2 Manufacturers Profiles
2.1 Bracco
2.1.1 Bracco Details
2.1.2 Bracco Major Business
2.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Product and Services
2.1.4 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 General Electric
2.2.1 General Electric Details
2.2.2 General Electric Major Business
2.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Product and Services
2.2.4 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Guerbet
2.3.1 Guerbet Details
2.3.2 Guerbet Major Business
2.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Product and Services
2.3.4 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Fujifilm Visualsonics
2.4.1 Fujifilm Visualsonics Details
2.4.2 Fujifilm Visualsonics Major Business
2.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product and Services
2.4.4 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Imax
2.5.1 Imax Details
2.5.2 Imax Major Business
2.5.3 Imax Interventional X-ray Contrast and Imaging Agents Product and Services
2.5.4 Imax Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 J.B. Chemicals & Pharmaceuticals
2.6.1 J.B. Chemicals & Pharmaceuticals Details
2.6.2 J.B. Chemicals & Pharmaceuticals Major Business
2.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product and Services
2.6.4 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Jodas Expoim
2.7.1 Jodas Expoim Details
2.7.2 Jodas Expoim Major Business
2.7.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product and Services
2.7.4 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Lantheus Medical Imaging
2.8.1 Lantheus Medical Imaging Details
2.8.2 Lantheus Medical Imaging Major Business
2.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product and Services
2.8.4 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Nano Therapeutics
2.9.1 Nano Therapeutics Details
2.9.2 Nano Therapeutics Major Business
2.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product and Services
2.9.4 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Novalek Pharmaceuticals
2.10.1 Novalek Pharmaceuticals Details
2.10.2 Novalek Pharmaceuticals Major Business
2.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product and Services
2.10.4 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Taejoon Pharm
2.11.1 Taejoon Pharm Details
2.11.2 Taejoon Pharm Major Business
2.11.3 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product and Services
2.11.4 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Unijules Life Sciences
2.12.1 Unijules Life Sciences Details
2.12.2 Unijules Life Sciences Major Business
2.12.3 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product and Services
2.12.4 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Interventional X-ray Contrast and Imaging Agents Sales by Manufacturer
3.1 Global Interventional X-ray Contrast and Imaging Agents Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Interventional X-ray Contrast and Imaging Agents
3.4 Market Concentration Rate
3.4.1 Top 3 Interventional X-ray Contrast and Imaging Agents Manufacturer Market Share
3.4.2 Top 6 Interventional X-ray Contrast and Imaging Agents Manufacturer Market Share
3.5 Global Interventional X-ray Contrast and Imaging Agents Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Interventional X-ray Contrast and Imaging Agents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Interventional X-ray Contrast and Imaging Agents Market Size by Region
4.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales in Volume by Region (2016-2026)
4.1.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2016-2026)
4.2 North America Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026)
4.3 Europe Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026)
4.4 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026)
4.5 South America Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026)
4.6 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Interventional X-ray Contrast and Imaging Agents Sales in Volume by Type (2016-2026)
5.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2016-2026)
5.3 Global Interventional X-ray Contrast and Imaging Agents Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Interventional X-ray Contrast and Imaging Agents Sales in Volume by Application (2016-2026)
6.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2016-2026)
6.3 Global Interventional X-ray Contrast and Imaging Agents Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2026)
7.2 North America Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2026)
7.3 North America Interventional X-ray Contrast and Imaging Agents Market Size by Country
7.3.1 North America Interventional X-ray Contrast and Imaging Agents Sales in Volume by Country (2016-2026)
7.3.2 North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2026)
8.2 Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2026)
8.3 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Country
8.3.1 Europe Interventional X-ray Contrast and Imaging Agents Sales in Volume by Country (2016-2026)
8.3.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2026)
9.2 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2026)
9.3 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Market Size by Region
9.3.1 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2026)
10.2 South America Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2026)
10.3 South America Interventional X-ray Contrast and Imaging Agents Market Size by Country
10.3.1 South America Interventional X-ray Contrast and Imaging Agents Sales in Volume by Country (2016-2026)
10.3.2 South America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2026)
11.2 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2026)
11.3 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Market Size by Country
11.3.1 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Interventional X-ray Contrast and Imaging Agents Typical Distributors
12.3 Interventional X-ray Contrast and Imaging Agents Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Interventional X-ray Contrast and Imaging Agents Revenue by Type, (USD Million), 2021-2026
Table 2. Global Interventional X-ray Contrast and Imaging Agents Revenue by Application, (USD Million), 2021-2026
Table 3. Bracco Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Major Business
Table 5. Bracco Interventional X-ray Contrast and Imaging Agents Product and Services
Table 6. Bracco Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. General Electric Basic Information, Manufacturing Base and Competitors
Table 8. General Electric Major Business
Table 9. General Electric Interventional X-ray Contrast and Imaging Agents Product and Services
Table 10. General Electric Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Guerbet Basic Information, Manufacturing Base and Competitors
Table 12. Guerbet Major Business
Table 13. Guerbet Interventional X-ray Contrast and Imaging Agents Product and Services
Table 14. Guerbet Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Fujifilm Visualsonics Basic Information, Manufacturing Base and Competitors
Table 16. Fujifilm Visualsonics Major Business
Table 17. Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product and Services
Table 18. Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Imax Basic Information, Manufacturing Base and Competitors
Table 20. Imax Major Business
Table 21. Imax Interventional X-ray Contrast and Imaging Agents Product and Services
Table 22. Imax Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. J.B. Chemicals & Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. J.B. Chemicals & Pharmaceuticals Major Business
Table 25. J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product and Services
Table 26. J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Jodas Expoim Basic Information, Manufacturing Base and Competitors
Table 28. Jodas Expoim Major Business
Table 29. Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product and Services
Table 30. Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lantheus Medical Imaging Basic Information, Manufacturing Base and Competitors
Table 32. Lantheus Medical Imaging Major Business
Table 33. Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product and Services
Table 34. Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Nano Therapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Nano Therapeutics Major Business
Table 37. Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product and Services
Table 38. Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Novalek Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Novalek Pharmaceuticals Major Business
Table 41. Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product and Services
Table 42. Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Taejoon Pharm Basic Information, Manufacturing Base and Competitors
Table 44. Taejoon Pharm Major Business
Table 45. Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product and Services
Table 46. Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Unijules Life Sciences Basic Information, Manufacturing Base and Competitors
Table 48. Unijules Life Sciences Major Business
Table 49. Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product and Services
Table 50. Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturer (2019-2021e) & (K MT)
Table 52. Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Interventional X-ray Contrast and Imaging Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Interventional X-ray Contrast and Imaging Agents Production Capacity by Company, (K MT): 2020 VS 2021
Table 55. Head Office and Interventional X-ray Contrast and Imaging Agents Production Site of Key Manufacturer
Table 56. Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2016-2021e) & (K MT)
Table 57. Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2021-2026) & (K MT)
Table 58. Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2021e) & (K MT)
Table 61. Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2021-2026) & (K MT)
Table 62. Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Interventional X-ray Contrast and Imaging Agents Price by Type (2016-2021e) & (USD/MT)
Table 65. Global Interventional X-ray Contrast and Imaging Agents Price by Type (2021-2026) & (USD/MT)
Table 66. Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2021e) & (K MT)
Table 67. Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2021-2026) & (K MT)
Table 68. Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Interventional X-ray Contrast and Imaging Agents Price by Application (2016-2021e) & (USD/MT)
Table 71. Global Interventional X-ray Contrast and Imaging Agents Price by Application (2021-2026) & (USD/MT)
Table 72. North America Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021e) & (K MT)
Table 73. North America Interventional X-ray Contrast and Imaging Agents Sales by Country (2021-2026) & (K MT)
Table 74. North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2021e) & (K MT)
Table 77. North America Interventional X-ray Contrast and Imaging Agents Sales by Type (2021-2026) & (K MT)
Table 78. North America Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2021e) & (K MT)
Table 79. North America Interventional X-ray Contrast and Imaging Agents Sales by Application (2021-2026) & (K MT)
Table 80. Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021e) & (K MT)
Table 81. Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2021-2026) & (K MT)
Table 82. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2021e) & (K MT)
Table 85. Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2021-2026) & (K MT)
Table 86. Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2021e) & (K MT)
Table 87. Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2021-2026) & (K MT)
Table 88. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales by Region (2016-2021e) & (K MT)
Table 89. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales by Region (2021-2026) & (K MT)
Table 90. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2021e) & (K MT)
Table 93. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales by Type (2021-2026) & (K MT)
Table 94. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2021e) & (K MT)
Table 95. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales by Application (2021-2026) & (K MT)
Table 96. South America Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021e) & (K MT)
Table 97. South America Interventional X-ray Contrast and Imaging Agents Sales by Country (2021-2026) & (K MT)
Table 98. South America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2021e) & (K MT)
Table 101. South America Interventional X-ray Contrast and Imaging Agents Sales by Type (2021-2026) & (K MT)
Table 102. South America Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2021e) & (K MT)
Table 103. South America Interventional X-ray Contrast and Imaging Agents Sales by Application (2021-2026) & (K MT)
Table 104. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021e) & (K MT)
Table 105. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales by Country (2021-2026) & (K MT)
Table 106. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2021e) & (K MT)
Table 109. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales by Type (2021-2026) & (K MT)
Table 110. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2021e) & (K MT)
Table 111. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales by Application (2021-2026) & (K MT)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Interventional X-ray Contrast and Imaging Agents Typical Distributors
Table 115. Interventional X-ray Contrast and Imaging Agents Typical Customers
List of Figures
Figure 1. Interventional X-ray Contrast and Imaging Agents Picture
Figure 2. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type in 2020
Figure 3. Iodinated Contrast Media
Figure 4. Barium-Based Contrast Media
Figure 5. Microbubble Contrast Media
Figure 6. Other
Figure 7. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application in 2020
Figure 8. Heart Disease
Figure 9. Neurological
Figure 10. Urology
Figure 11. General Surgery
Figure 12. Other
Figure 13. Global Interventional X-ray Contrast and Imaging Agents Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 14. Global Interventional X-ray Contrast and Imaging Agents Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Interventional X-ray Contrast and Imaging Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Interventional X-ray Contrast and Imaging Agents Sales (2016-2026) & (K MT)
Figure 35. Global Interventional X-ray Contrast and Imaging Agents Production Capacity (2016-2026) & (K MT)
Figure 36. Global Interventional X-ray Contrast and Imaging Agents Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Interventional X-ray Contrast and Imaging Agents Market Drivers
Figure 38. Interventional X-ray Contrast and Imaging Agents Market Restraints
Figure 39. Interventional X-ray Contrast and Imaging Agents Market Trends
Figure 40. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturer in 2020
Figure 41. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Manufacturer in 2020
Figure 42. Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Interventional X-ray Contrast and Imaging Agents Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Interventional X-ray Contrast and Imaging Agents Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2016-2026)
Figure 46. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2016-2026)
Figure 47. North America Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026) & (USD Million)
Figure 48. Europe Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026) & (USD Million)
Figure 50. South America Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Revenue (2016-2026) & (USD Million)
Figure 52. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2016-2026)
Figure 53. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2016-2026)
Figure 54. Global Interventional X-ray Contrast and Imaging Agents Price by Type (2016-2026) & (USD/MT)
Figure 55. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2016-2026)
Figure 56. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2016-2026)
Figure 57. Global Interventional X-ray Contrast and Imaging Agents Price by Application (2016-2026) & (USD/MT)
Figure 58. North America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Country (2016-2026)
Figure 59. North America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Country (2016-2026)
Figure 60. North America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2016-2026)
Figure 61. North America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2016-2026)
Figure 62. Europe Interventional X-ray Contrast and Imaging Agents Sales Market Share by Country (2016-2026)
Figure 63. Europe Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Country (2016-2026)
Figure 64. Europe Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2016-2026)
Figure 65. Europe Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2016-2026)
Figure 70. South America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Country (2016-2026)
Figure 71. South America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Country (2016-2026)
Figure 72. South America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2016-2026)
Figure 73. South America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
MRI造影剤の世界市場2018-2025 MRI Contrast Media is contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI) The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues fol…- 世界の血管造影用造影剤市場 2021：企業別、地域別、種類・用途別 The Angiography Contrast Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- コントラストメディアインジェクターの世界市場2018-2025 Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in tissues.The key factors contributing to the contrast media injectors market are technological advancements and increasing demand for minimally invasive surgeries. The Contrast Media In…
- 世界の医療用造影剤注入装置市場 2021：企業別、地域別、種類・用途別 The Medical Contrast Media Injectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- コントラストインジェクターの世界市場2018-2025 Contrast injectors are used in medical imaging for injecting contrast media into the blood vessels and in certain cases, through oral administration, to obtain pictures that are better than those produced without injecting a contrast. This gives a better insight into problems related to the fields o…